Q&A with Poolbeg Pharma CEO, Jeremy Skillington
Episode 2105
Watch on YouTube
Following on from its £4.865 million raise last week,
Poolbeg #POLB has announced that it has received FDA Orphan Drug Designation for POLB 001. Chief executive Jeremy Skillington joins us to tell us what it all means.
Published on 6 months, 3 weeks ago